
|Articles|May 1, 2004
Acitretin therapy yields double benefit for patient with psoriasis, skin cancer
Data on new lesion development during follow-up shows drug is effective in simultaneous control of both conditions
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
4
Reviewing the Overarching Umbrella of Psoriatic Disease
5

















